Synthon keeps growing. With our extension of Synthon Hispania (SHIS, we will enhance our R&D capacity and expand our production capacity.
Scroll
View
Swipe
Play
Jan 2026
Extension Synthon Hispania
The company will invest 15 million euros in the extension project to expand the facilities that allow SHIS to enhance its R&D capacity and expand production capacity. The expansion will contribute to Synthon group’s development of pharmaceutical products and the capacity for their commercialization. With more space to stay up-to-date on the latest scientific developments, we can continuously improve our products and processes.
The project will be developed in three phases over 4 years.
With the collaboration of ACCIÓ



